Synthetic biology and biofermentation for natural products
Strategic Profile
Founded in 2015 and headquartered in Emeryville, the company focuses on biotechnology applications in cannabinoid production. The global market for cannabinoids is expected to reach $100 billion by 2029. Demetrix addresses supply chain limitations by replacing traditional plant cultivation with fermentation-based production of high-purity cannabinoids.
Cyborg Score Rationale
Demetrix possesses strong technology (University of California, Berkeley-licensed fermentation platform) and significant funding (>$60 million raised as of 2019), positioning it in a large emerging market. However, limited recent public disclosure, small team (~21 employees), and estimated revenue of $3.8M indicate early commercialization stage with execution risks.
Top Insights
Core technology leverages baker's yeast fermentation to produce rare cannabinoids economically—solving a key supply chain constraint where traditional plant extraction cannot economically produce low-concentration compounds
Licensed breakthrough technology from UC Berkeley enables production of rare cannabinoids at commercial scale and affordable cost
Business model targets B2B partnerships in pharmaceutical, supplement, and consumer product sectors rather than direct-to-consumer
Small headcount (~21 employees) and limited recent funding announcements suggest slower commercialization or pivot in strategy since Series A (July 2019)
Named Competitors
Ginkgo Bioworks — Cell programming platform for synthetic biology across chemicals, food, and materials
Impossible Foods — Fermentation-based plant-derived protein production for alternative meat
Traditional Cannabis Cultivation & Extraction — Cannabis and cannabinoid extraction via traditional plant cultivation
Recent Developments
(July 2019) Secured $50 million Series A funding led by Tuatara Capital with participation from existing investor Horizons Ventures
(February 2021) Completed $19.09 million funding round in venture capital
No major public announcements or product launches disclosed post-2021
Open the full interactive Demetrix, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.